Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Bethesda, Maryland 20814


Purpose:

The purpose of this study is to assess GBR 12909 in cocaine experienced African American Volunteers.


Study summary:

Double-blind, placebo-controlled, safety and pharmacology study with 75 mg dosage of GBR 12909 in cocaine experienced African American Volunteers. Particular interest is being given to the hematological safety data.


Criteria:

Inclusion Criteria: - Must be within 20% of ideal body weight and must weigh at least 45 kg. - Must understand the study procedures and provide written informed consent. - Must meet DSM-4 criteria for abuse or dependence on cocaine. - Must be non-treatment seeking at the time of the study. Exclusion Criteria: - Please contact the study site for more information.


NCT ID:

NCT00089687


Primary Contact:

Principal Investigator
Louis Cantilena, M.D.
Uniformed Services University of Health Science


Backup Contact:

N/A


Location Contact:

Bethesda, Maryland 20814
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: December 15, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.